One Belt One Road: Probationary bonanza
China’s One Belt One Road agenda is set to be a driving force in M&A activity that reshapes economies across Eurasia for decades to come. Early movers are consequently negotiating a new world of variables
M&A deal makers do not typically consider Albania a key gateway to Europe. But as China’s One Belt One Road (OBOR) policy comes increasingly into focus, this might be one of many areas of conventional...
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.